Abstract:Abstract Introduction Prior work has established substantial overlap in polysomnography features between synucleinopathy-associated RBD and PTSD/TASD-associated RBD (trauma-associated-sleep-disorders). However, our mechanistic understanding remains limited. To explore RBD endophenotypes, we applied a novel analysis for clustering and categorizing PSG without AI/ML or sleep scoring, Spectral-Band Cluster-Prevalence (SBCP), to examine and compare differences in EEG characteristics between patients with RBD diagnosis versus clinical controls. Methods Our data source was retrospective EEG/EOG recordings from N=124 PSG participants (age=57.5 [SD=15]) including n=74 RBD diagnosed patients (defined by PSG findiings and patient-reported dream-enactment) with n=50 clinical controls (AHI< 15). EEG-channels were excluded based on artifacts, normalized to max voltage, EOG-channels were normalized to in-channel voltage, and extracted into ten-second segments. Signal features were extracted for each segment: EEG delta(1-4Hz), theta(4-8Hz), alpha(8-12Hz), beta(12-30Hz) spectral band-powers and EOG broadband-powers. Feature EEG band-powers were projected into 3-dimensional subspace, where optimal parameters for Gaussian Mixture Model (GMM) were identified to allow for mixed EEG states. Cluster quality measures Silhouette, Davies-Bouldin, Akaike-Information-Criterion were evaluated to determine the optimal number of components (i.e. unique EEG states) required by the GMM to maximize the explained variance based on global optima in cluster quality values. Dwell-Fraction was estimated by assigning components to ten-second EEG segments, and used to report between-groups differences. Results GMM global optima identified n=3 components as the optimal number to describe short segments of EEG/EOG measured by how well the components explain RBD-associated between-group differences, showing the highest cluster quality values observed across all 3 cluster quality measures. Dwell-Fraction (defined as: percentage of total-sleep-time spent in each component), revealed statistically significant differences associated with RBD (Component-3: RBD>Controls) and clinical controls (Component-1: Controls>RBD) based on Mann-Whitney-U and t-test results. ROC-AUCs were calculated for classifying RBD-vs-Controls, based only on the Dwell-Fraction (Component-3: 0.65, Component-1: 0.57, Component-2: 0.52). Relative to Component-1, which best described controls, Component-2 best described RBD. Further, Component-2 showed band-power distributions associated with RBD including significantly higher theta/alpha band-power in EOG-channels, lower delta/beta band-power in EEG frontal-channels, and higher delta band-power in EEG central-channels. Conclusion Spectral-Band Cluster-Prevalence has potential applications to improve identification of RBD and RBD subtype-specific EEG biomarkers associated with synucleinopathy and PTSD/TASD. Support (if any)

0670 Patterns of Nocturnal Sleep Disruption: Differentiating IH from NT2 Using Cluster Analysis

Nocturnal sleep phenotypes in idiopathic hypersomnia - A data-driven cluster analysis

Probabilistic Sleep Staging in MSLTs across Hypersomnia Disorders

Identifying time‐resolved features of nocturnal sleep characteristics of narcolepsy using machine learning

0599 Sleep Stage Transition Patterns Among Youth with CNS Disorders of Hypersomnolence

Comparative Polysomnography Parameters Between Narcolepsy Type 1/type 2 and Idiopathic Hypersomnia: A Systematic Review and Meta-Analysis.

Temporal patterns of sleep latency in central hypersomnia and attention deficit hyperactivity disorder: a cluster analysis exploration using Multiple Sleep Latency Test

Differential characteristics of repeated polysomnography and multiple sleep latency test parameters in narcolepsy type 1 and type 2 patients: a longitudinal retrospective study

Altered functional connectivity and spatiotemporal dynamics in individuals with sleep disorders

0710 REM Behavior Disorder Explainability in EEG via Spectral Band Cluster Prevalence

Distinguishing between children referred for assessment of excessive daytime sleepiness using polysomnographic measures.

0667 Narcolepsy & Idiopathic Hypersomnia Patient Journey, Clinical Features and Treatments in a Real-World US Population

Altered Sleep Stage Transitions of REM Sleep: A Novel and Stable Biomarker of Narcolepsy

Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2

1176 Extended Polysomnography Confirms Idiopathic Hypersomnia Diagnoses: A Case Series

0820 Integrated Polysomnographic and Sleep Symptom-Based Cluster Subtypes Associated with Incident Atrial Fibrillation

0428 Comparative Analysis of Sleep Physiology Using Qualitative and Quantitative Criteria for Insomnia Symptoms

Characterizing disrupted nighttime sleep and associated functional outcomes in youth with narcolepsy type 1

Neurophysiological Parameters Influencing Sleep–Wake Discrepancy in Insomnia Disorder: A Preliminary Analysis on Alpha Rhythm during Sleep Onset

Regional brain metabolism differs between narcolepsy type 1 and idiopathic hypersomnia

P022 Sleep Biomarker Phenotyping of Neurodegenerative Disorders Using Artificial Intelligence – A Pilot Study